search
Back to results

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

Primary Purpose

Chronic Obstructive Pulmonary Disease

Status
Completed
Phase
Locations
Sweden
Study Type
Observational
Intervention
Sponsored by
AstraZeneca
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an observational trial for Chronic Obstructive Pulmonary Disease focused on measuring COPD, COPD-6, Spirometry, VC, FEV, FEV1

Eligibility Criteria

45 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with a history of smoking one pack of cigarettes per day for 15 years or more

Exclusion Criteria:

  • Known Chronic Obstructive Pulmonary Disease
  • Known severe cardiovascular disease

Sites / Locations

  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site

Arms of the Study

Arm 1

Arm Type

Arm Label

No treatment

Arm Description

Patients with a smoking history of 15 pack years or more.

Outcomes

Primary Outcome Measures

The patients will test their lung function with a COPD-6 screener for COPD and compare with regular spirometry. Medical records will be checked for health care contacts with respiratory diagnosis during the last 24 months prior to the study visit.

Secondary Outcome Measures

Full Information

First Posted
November 13, 2009
Last Updated
November 18, 2010
Sponsor
AstraZeneca
search

1. Study Identification

Unique Protocol Identification Number
NCT01013922
Brief Title
A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting
Official Title
A Descriptive Study to Explore Certain Characteristics of Patients at Risk for COPD in a Primary Care Setting
Study Type
Observational

2. Study Status

Record Verification Date
November 2010
Overall Recruitment Status
Completed
Study Start Date
October 2009 (undefined)
Primary Completion Date
March 2010 (Actual)
Study Completion Date
March 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
AstraZeneca

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to explore if certain characteristics, easily detected within a regular primary care setting, may indicate that a patient at risk for COPD (45 ≤ age ≤ 80 years and a smoking history of ≥ 15 pack years) is prone to have a diagnosis of COPD according to Medical Products Agency guidelines.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Obstructive Pulmonary Disease
Keywords
COPD, COPD-6, Spirometry, VC, FEV, FEV1

7. Study Design

Enrollment
309 (Actual)

8. Arms, Groups, and Interventions

Arm Title
No treatment
Arm Description
Patients with a smoking history of 15 pack years or more.
Primary Outcome Measure Information:
Title
The patients will test their lung function with a COPD-6 screener for COPD and compare with regular spirometry. Medical records will be checked for health care contacts with respiratory diagnosis during the last 24 months prior to the study visit.
Time Frame
There will only be one visit in the study

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with a history of smoking one pack of cigarettes per day for 15 years or more Exclusion Criteria: Known Chronic Obstructive Pulmonary Disease Known severe cardiovascular disease
Study Population Description
Primary care clinic
Sampling Method
Non-Probability Sample
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Björn Tilling
Organizational Affiliation
Åtvidabergs vårdcentral
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Georgios Stratelis
Organizational Affiliation
AstraZeneca
Official's Role
Study Director
Facility Information:
Facility Name
Research Site
City
Alingsas
Country
Sweden
Facility Name
Research Site
City
Arvidsjaur
Country
Sweden
Facility Name
Research Site
City
Askim
Country
Sweden
Facility Name
Research Site
City
Atvidaberg
Country
Sweden
Facility Name
Research Site
City
Bromma
Country
Sweden
Facility Name
Research Site
City
Eslov
Country
Sweden
Facility Name
Research Site
City
Falun
Country
Sweden
Facility Name
Research Site
City
Gagnef
Country
Sweden
Facility Name
Research Site
City
Goteborg
Country
Sweden
Facility Name
Research Site
City
Hagfors
Country
Sweden
Facility Name
Research Site
City
Helsingborg
Country
Sweden
Facility Name
Research Site
City
Hisings Karra
Country
Sweden
Facility Name
Research Site
City
Hollviken
Country
Sweden
Facility Name
Research Site
City
Jarpen
Country
Sweden
Facility Name
Research Site
City
Karlshamn
Country
Sweden
Facility Name
Research Site
City
Karlskrona
Country
Sweden
Facility Name
Research Site
City
Kil
Country
Sweden
Facility Name
Research Site
City
Limhamn
Country
Sweden
Facility Name
Research Site
City
Linkoping
Country
Sweden
Facility Name
Research Site
City
Lulea
Country
Sweden
Facility Name
Research Site
City
Stockholm
Country
Sweden
Facility Name
Research Site
City
Timra
Country
Sweden
Facility Name
Research Site
City
Varnamo
Country
Sweden

12. IPD Sharing Statement

Citations:
PubMed Identifier
22270480
Citation
Thorn J, Tilling B, Lisspers K, Jorgensen L, Stenling A, Stratelis G. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim Care Respir J. 2012 Jun;21(2):159-66. doi: 10.4104/pcrj.2011.00104.
Results Reference
derived

Learn more about this trial

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

We'll reach out to this number within 24 hrs